MGMT and glioblastoma: Scalp sparing radiation with concurrent temozolomide and TTF is well tolerated by patients, furthermore, a better response for glioblastoma patients with methylated O6-methylguanine DNA methyltransferase (MGMT) promoter has been observed [52,53,80].